3 replies to this topic

[ironfistx]

Thread from a year ago.  Forbes says it's good: www.forbes.com/sites/stevensalzberg/2023/06/13/a-dietary-supplement-that-might-really-work

 

News articles from a few days ago:

 

https://www.westernm...n-blood-cancer/

 

https://people.com/c...cancer-11735858

 

https://www.fox9.com...er-growth-study

 

https://www.northjer...ng/83673571007/

 

 

[Vitalist]

A guy on X did a good job of debunking that article. 

 

Let's look at the ACTUAL study published in Nature before everyone gets completely hysterical. 

 

1. It focused specifically on MYELOID LEUKEMIA in mice, not humans or other cancers 

 

2. The research primarily looked at endogenous taurine PRODUCED WITHIN BONE MARROW, not supplemental taurine 

 

3. The study was a pre-existing disease model -- it used mice that ALREADY HAD LEUKEMIA or were genetically modified to develop it 

 

4. Many of the experiments involved GENETIC DELETION of taurine transporters... not exactly the same as taking or avoiding a supplement

 

 

 

https://x.com/MicroB...597491359744317

[Mind]

It is amazing how much poor science exists in the medical/nutrition research space. Here is a LongeCity thread that has been covering the scandal for many years.

 

This particular paper is not "junk" or "fraudulent", only that it is not likely relevant to humans. Unfortunately, the popular media in the US is terrible and portrays everything as "the end of the world".

[Chopi]

"The preclinical research shows that scientists are a step closer to finding new ways to target leukemia, which is one of the most aggressive blood cancers. The Wilmot Cancer Institute investigators at the University of Rochester were able to block the growth of leukemia in mouse models and in human leukemia cell samples by using genetic tools to prevent taurine from entering cancer cells."

 

 

So that was a study on mice and human cell lines.

A Japanese study of actual leukemia patients from 1983.

 

https://www.med.nago...45n34p89_96.pdf

 

Intracellular levels of the free amino acid taurine were measured in circulating granulocytes and
mononuclear cells from 12 normal subjects and 27 patients with various types of leukemia, and in bone marrow cells from seven acute leukemias in blastic phase and 4 in remission. leukemic cells have consistently lower taurine levels compared to normal lymphocytes and granulocytes. Although taurine levels in the circulating granulocytes from patients with acute and chronic leukemias were normal, they were significantly lower in the group of patients with atypical AML. The lowest taurine levels were observed in ihe mononuclear cells from patients with AMl and All followed by those from patients with CMl and Cll, and then those from patients with atypical AML .ln AMl patients the levels increased to normal values during clinical remission. The bone marrow mononuclear cells of AMl in the blastic phase also had lower taurine levels compared to these in remission just same as peripheral blood cells do. These observations on the alteration in taurine content of both mononuclear cells in peripheral blood and bone marrow may be useful as a biochemical marker in diagnosis as well as for prediction of relapse and effectiveness of chemotherapy on patients with various types of leukemia.